Medix Biochemica, a leading provider of essential raw materials for the in vitro diagnostics (IVD) industry, has successfully raised €681 million in a significant funding round. With its roots deeply embedded in Finland, the company has expanded its operations globally, supplying high-quality antibodies, antigens, and other critical materials to IVD partners around the world. This substantial investment underscores the growing demand for accurate diagnostic tests and highlights Medix Biochemica's commitment to delivering excellence in the healthcare sector. The funding will be strategically utilized to enhance the company's capabilities in developing innovative diagnostic reagents, expand its biospecimen offerings, and elevate custom services that cater to the unique needs of its partners. By leveraging this financial boost, Medix Biochemica aims to accelerate its research and development efforts, ensuring a swift time to market for its IVD customers. As the company continues to grow its comprehensive portfolio of raw materials, it remains dedicated to building quality and reliability into every product. With a team comprised of industry experts, Medix Biochemica is poised to transform the landscape of diagnostics, helping to deliver life-saving tests to billions of patients around the globe. "Whatever you need, chances are we IVDo that," is not just a tagline; it's a promise of Medix Biochemica’s unwavering commitment to innovation and excellence in the diagnostics industry. Visit our website to learn more about our offerings and our vision for the future of healthcare.
Medix Biochemica Secures $681M Funding to Transform Global IVD Industry
Recently funded · $681.0MBiotechnology
Get the full Medix Biochemica company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
